We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

MYOCARDIAL INFARCTION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2021 - 2028)

Myocardial Infarction Market, By Drug Class (Antiplatelet Agents, Glycoprotein IIb/IIIa Inhibitors, Antithrombotic Agents, Beta-adrenergic Blockers, Vasodilators, Angiotensin-converting Enzyme (ACE) Inhibitors, Angiotensin-receptor Blockers, Analgesics and Thrombolytics), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In: 17 Aug, 2021
Code: CMI4585
Page number: 167
Formats: Excel and PDF
Industry: Pharmaceutical

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Class
  - Market Snippet, By Route of Administration
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Porter’s Analysis
- Industry Trends
- Key Highlights
- Epidemiology
- Reimbursement Scenario
- Regulatory Scenario
- Product Launch and Approvals
- Acquisition and Collaboration Scenario
Global Myocardial Infarction Market - Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Impact of COVID-19 on Demand and Supply of Myocardial Infarction Treatment
- Impact of COVID-19 on the overall Healthcare Sector
Global Myocardial Infarction Market, By Drug Class, 2017 - 2028 (US$ Million)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 - 2028
  - Segment Trends
- Antiplatelet Agents
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Glycoprotein IIb/IIIa Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Antithrombotic Agents
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Beta-adrenergic Blockers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Vasodilators
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Angiotensin-converting Enzyme (ACE) Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Angiotensin-receptor Blockers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Analgesics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Thrombolytics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Global Myocardial Infarction Market, By Route of Administration, 2017 - 2028 (US$ Million)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 - 2028
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Injectable
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Global Myocardial Infarction Market, By Distribution Channel, 2017 - 2028 (US$ Million)
- Introduction
  - Market Share Analysis, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, 2018 - 2028
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Global Myocardial Infarction Market, By Region, 2017 - 2028 (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2021 and 2028 (%)
  - Y-o-Y Growth Analysis, For Regions, 2018 - 2028
  - Regional Trends
- North America
  - Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    - U.S.
    - Canada
- Latin America
  - Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Country, 2017 - 2028 (US$ Mn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Market Size and Forecast, By Drug Class, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Mn)
  - Market Size and Forecast, By Country/Region, 2017 - 2028 (US$ Mn)
    - South Africa
    - Central Africa
    - North Africa
Competitive Landscape
- Company Profiles
  - Bristol-Myers Squibb Co *
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Recent Developments/Updates
    - Strategies
  - Bayer AG
  - Johnson & Johnson Services Inc.
  - Sanofi S.A.
  - Novartis International AG
  - AstraZeneca plc.
  - Daiichi Sankyo Co Ltd
  - Boehringer Ingelheim International GmbH
  - Pfizer Inc.
  - Merck KGaA.

*Key pointers provided are also applicable to other companies covered in the scope of the report.

- Analyst Views

Section
- Research Methodology
- About us
- Contact

*Browse 33 market data tables and 25 figures on “Myocardial Infarction Market” - Global Forecast to 2028.

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now